SEOUL, South Korea, Dec. 5, 2024 /PRNewswire/ -- Neurophet, an artificial intelligence (AI) solution company for brain disease, announced its participation in the Radiological Society of North America ...

New features include advanced analysis of multiple sclerosis (MS) and white matter hyperintensities alongside brain atrophy ...

[31] Brain lesions associated with this virus showed mixed hyperintensity on T2-W and FLAIR sequences, with hypointensity on T1-W imaging. MRI: abnormal findings by conventional MRI sequences ...

The FDA cleared an extended version of Neurophet AQUA that uses AI for analysis in counting and measuring MS brain lesions on ...